Bixiye
P69-17 New Reimbursement Policy for Inpatient Facility: Inpatient Short Stay
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2017
Natiijooyinka Raadinta
Soo bandhiga 3181 - 3190 ee natiijooyinka 3688
Bixiye
P74-17 Payment Methodology Change for Interim Billing
Taariikhda uu dhaqangalayo Barnaamijka: Nov 29, 2017
Bixiye
P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2018
Bixiye
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2017
Bixiye
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Mar 21, 2017
Bixiye
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017
Bixiye
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2018
Bixiye
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P49-17 Two New Medicare Advantage Prescription Drug Products in 2018
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2017